Filter Results :

Your search for Neural returned 31 reports

Sort by


Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative anal...

$ 2,000.00

Read More

Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

09 Jan 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 300.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative ana...

$ 2,000.00

Read More

Trigeminal Neuralgia - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Trigeminal Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutic...

$ 2,000.00

Read More

Neuralstem, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Nov 2014  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule

14 Nov 2014  |  Published by:  World Market Intelligence
Synopsis"Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees.SummaryThis report...

$ 75.00

Read More

Neuralgia Partnering 2009-2014

01 Nov 2014  |  Published by:  CurrentPartnering
The Neuralgia Partnering 2009-2014 provides understanding and access to the neuralgia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of neuralgia partnering deals. The majority of deals are discovery or development st...

$ 695.00

Read More

Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile

20 Oct 2014  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Postherpetic Neuralgia - Pipeline Review, H2 2014

31 Aug 2014  |  Published by:  Global Markets Direct
Summary‘Postherpetic Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Postherpetic Neuralgia, complete with comparative analysis at various stages, therap...

$ 2,000.00

Read More

Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014

12 Aug 2014  |  Published by:  GlobalData
Summary“Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Trigeminal Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trigeminal Neuralgia. It includes an overview of the trial numbers and their...

$ 2,500.00

Read More

Postherpetic Neuralgia-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Postherpetic Neuralgia-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Postherpetic Neuralgia. This report provides inform...

$ 1,250.00

Read More

Neuralgia-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Neuralgia-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Neuralgia. This report provides information on the therapeutic d...

$ 1,250.00

Read More

Acute Sensorineural Hearing Loss-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Acute Sensorineural Hearing Loss-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Acute Sensorineural Hearing Loss. This re...

$ 1,250.00

Read More

Postherpetic Neuralgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'Postherpetic Neuralgia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API ...

$ 2,000.00

Read More

Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014

28 Jul 2014  |  Published by:  GlobalData
Summary“Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Postherpetic Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Postherpetic Neuralgia. It includes an overview of the trial numbers and...

$ 2,500.00

Read More
Total 31 records.